Dexcel offers a broad range of value – added
branded and generic products. For an updated
product list check the below table
Dexcel Pharma’s proprietary formulation of Omeprazole 20mg Delayed Release tablet was launched in March 2008 as the first OTC store brand equivalent to Prilosec OTC®. This high quality, value saving alternative has been the market leader since launch.
Through an exclusive partnership with Perrigo, Dexcel’s Omeprazole OTC is sold in nearly every pharmacy chain across the US. The product continues to gain market share and produce year-over-year growth despite increased competition from new molecules hitting the OTC shelves.
In 2015, Dexcel’s Widlberry Mint Omeprazole OTC tablets were launched as an addition to the product line.
PerioChip® is an innovative, easy to apply, biodegradable chip containing 2.5 mg of chlorhexidine gluconate – a non antibiotic adjunct treatment to scaling and root planing (SRP) and is ideal for reducing pocket depth in patients with adult periodontitis.
PerioChip® is clinically effective and well tolerated in the treatment of periodontal pockets with depth of 5 mm and more.
Since launch, millions of chips have been administered by dental professionals across the globe, and our strong commitment to working closely with doctors and clinics helps them adopt PerioChip® into their practices as 1st line treatment for long-term growth.
PerioChip is manufactured in Israel and sold successfully in various countries around Europe, USA, Israel and the Asia- Pacific region.
The Dexcel Pharma team of formulation experts developed Deximune® – a soft-gelatin capsule formulation bio-equivalent to Neoral®.
Deximune® is an immunosuppressant used following transplants and in the field of Dermatology.
Deximune® is licensed for all Ciclosporin indications and is sold in various European countries, Israel & Singapore.